Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Matzke

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Clinical Pharmacy|September 1, 1982
Evaluation of a single-point method for predicting theophylline dosageR W McGory, G R Matzke
American Journal of Hospital Pharmacy|July 1, 1985
Particle formation of third-generation cephalosporin injectionsG H Carlson, G R Matzke
Therapeutic Drug Monitoring|January 1, 1984
Contribution of 5-(4-hydroxyphenyl)-5-phenylhydantoin to the discrepancy between phenytoin analyses by EMIT and high-pressure liquid chromatographyR J Sawchuk, G R Matzke
Transactions - American Society for Artificial Internal Organs|January 1, 1982
Cefsulodin pharmacokinetics during hemodialysisG R Matzke, W F Keane
Drug Intelligence & Clinical Pharmacy|October 1, 1987
Effects of renal insufficiency on the pharmacokinetics and pharmacodynamics of opioid analgesicsG L Chan, G R Matzke
Drug Intelligence & Clinical Pharmacy|May 1, 1981
Elevated serum phenytoin concentrations in a uremic patient when measured by enzyme-multiplied immunoassayG R Matzke, R J Sawchuk
Drug Safety|March 1, 1997
Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicityG R Matzke, R F Frye
Drug Intelligence & Clinical Pharmacy|January 1, 1981
The treatment of hypertension in pregnancyA L Wilson, G R Matzke
American Journal of Nephrology|January 1, 1984
Stability of gentamicin and tobramycin in concentrate solutions for automated peritoneal dialysisK S Nance, G R Matzke
Drug Intelligence & Clinical Pharmacy|November 1, 1983
Bumetanide: a new loop diuretic (Bumex, Roche Laboratories)C E Halstenson, G R Matzke
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Clinical Pharmacy|September 1, 1982
Evaluation of a single-point method for predicting theophylline dosageR W McGory, G R Matzke
American Journal of Hospital Pharmacy|July 1, 1985
Particle formation of third-generation cephalosporin injectionsG H Carlson, G R Matzke
Therapeutic Drug Monitoring|January 1, 1984
Contribution of 5-(4-hydroxyphenyl)-5-phenylhydantoin to the discrepancy between phenytoin analyses by EMIT and high-pressure liquid chromatographyR J Sawchuk, G R Matzke
Transactions - American Society for Artificial Internal Organs|January 1, 1982
Cefsulodin pharmacokinetics during hemodialysisG R Matzke, W F Keane
Drug Intelligence & Clinical Pharmacy|October 1, 1987
Effects of renal insufficiency on the pharmacokinetics and pharmacodynamics of opioid analgesicsG L Chan, G R Matzke
Drug Intelligence & Clinical Pharmacy|May 1, 1981
Elevated serum phenytoin concentrations in a uremic patient when measured by enzyme-multiplied immunoassayG R Matzke, R J Sawchuk
Drug Safety|March 1, 1997
Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicityG R Matzke, R F Frye
Drug Intelligence & Clinical Pharmacy|January 1, 1981
The treatment of hypertension in pregnancyA L Wilson, G R Matzke
American Journal of Nephrology|January 1, 1984
Stability of gentamicin and tobramycin in concentrate solutions for automated peritoneal dialysisK S Nance, G R Matzke
Drug Intelligence & Clinical Pharmacy|November 1, 1983
Bumetanide: a new loop diuretic (Bumex, Roche Laboratories)C E Halstenson, G R Matzke
Pageof 13